Guidance · United States medical-device regulatory submissions and labeling
FDA MR testing and labeling guidance, October 2023
MR safety, compatibility and labeling recommendations for medical devices within its stated scope, including independently supplied devices or accessories where applicable.
Application boundary: Excludes the MR system and associated components. Integrated scanner-table rails follow the OEM's equipment qualification, including the applicable IEC 60601-2-33 route. For those parts this nonbinding guidance provides hazard and terminology background, not a direct component approval or labeling route.
ReferencesFDA: testing and labeling medical devices in the MR environmentFDA MR guidance: full October 2023 documentIEC 60601-2-33:2022: diagnostic MR equipment